Avances terapéuticos en el manejo depletivo de la insuficiencia cardiaca

Contenido principal del artículo

MD Juan Santiago Serna – Trejos
MD Stefanya Geraldine Bermúdez – Moyano
MD Diego Gerardo Prado–Molina

Keywords

Abstract 23 | PDF Downloads 17

Citas

1. Rodríguez Roca G, Luis Llisterri Caro J, Javier Alonso Moreno F, Barrios Alonso V, Rodríguez Padial L. La insuficiencia cardíaca congestiva en atención primaria (y II). Semer - Med Fam [Internet]. 2000;26(2):66–76. Disponible en: doi:10.1016/s1138-3593(00)73536-2

2. Gómez-Mesa JE, Saldarriaga CI, Echeverría LE, Luna P. Colombian heart failure registry (RECOLFACA): methodology and preliminary data. Rev Colomb Cardiol [Internet]. 2021;28(3):217–30. Disponible en: doi:10.24875/RCCAR.M21000021

3. Gheorghiade M, Filippatos G. Reassessing treatment of acute heart failure syndromes: The ADHERE Registry. Eur Hear Journal, Suppl [Internet]. 2005;7(B):13–9. Disponible en: doi:10.1093/eurheartj/sui008

4. Biegus J, Zymlinski R, Siwolowski P, Testani J, Szachniewicz J, Tycińska A, et al. Controlled decongestion by Reprieve therapy in acute heart failure: results of the TARGET-1 and TARGET-2 studies. Eur J Heart Fail [Internet]. 2019;21(9):1079–87. Disponible en: doi:10.1002/ejhf.1533

5. Magenta Medical Ltd. Clinical Evaluation of the TRVD TM System in ADHF ( TRVD) [Internet]. 2019. Disponible en: https://clinicaltrials.gov/ct2/show/study/NCT03621436

6. WhiteSwell Ltd. Safety and Feasibility of the WhiteSwell System " (SWIFTHF) [Internet]. 2022. p. 1–4. Disponible en: https://clinicaltrials.gov/ct2/show/NCT02863796

7. AquaPass Medical Ltd. Effect of Enhanced Sweat Rate on the Safety and Edema Status of Chronic Edematous Patients [Internet]. 2022. Disponible en: https://clinicaltrials.gov/ct2/show/NCT04578353